Evidence map›Paper›PMID 36949973›Full record

ArticleCureus2023

Development of a Novel Ex Vivo Porcine Hepatic Segmental Perfusion Proof-of-Concept Model Towards More Ethical Translational Research.

Trisha Kanani, John Isherwood, Kareem ElSamani, Wen Y Chung, Kevin West, Marco R Oggioni, Giuseppe Garcea, Ashley Dennison

Open access · diamondFull text read
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Trisha KananiHepatobiliary and Pancreatic Surgery, University Hospitals of Leicester NHS (National Health Services) Trust, Leicester, GBR.
John IsherwoodHepatobiliary and Pancreatic Surgery, University Hospitals of Leicester NHS (National Health Services) Trust, Leicester, GBR.
Kareem ElSamaniHepatobiliary and Pancreatic Surgery, University Hospitals of Leicester NHS (National Health Services) Trust, Leicester, GBR.
Wen Y ChungHepatobiliary and Pancreatic Surgery, University Hospitals of Leicester NHS (National Health Services) Trust, Leicester, GBR.
Kevin WestHistopathology, University Hospitals of Leicester NHS (National Health Services) Trust, Leicester, GBR.
Marco R OggioniGenetics and Genome Biology, University of Leicester, Leicester, GBR.
Giuseppe GarceaHepatobiliary and Pancreatic Surgery, University Hospitals of Leicester NHS (National Health Services) Trust, Leicester, GBR.
Ashley DennisonHepatobiliary and Pancreatic Surgery, University Hospitals of Leicester NHS (National Health Services) Trust, Leicester, GBR.
University of Leicester · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction Ex vivo machine perfusion describes the technique where organs are continuously perfused and oxygenated extracorporeally (at physiological conditions) to maintain the organs' viability. To our knowledge, there are currently no reported studies describing ex vivo perfusion of a single hepatic segment. Here, we describe the development of a porcine ex vivo hepatic segmental perfusion model to demonstrate proof of concept and support further research into the ex vivo perfusion of the human liver using discarded tissue.  Methods Whole livers were retrieved from abattoir-derived pigs and connected to a normothermic extracorporeal perfusion circuit. Constant segmental perfusion via the common or segmental hepatic artery and portal vein with heparinised autologous blood was established. The viability of the perfused organ was assessed by monitoring perfusion pressures, flow rates and histology samples. Results Following perfusion and optimisation of the model for three hepatic segments, the third perfusion demonstrated viable hepatocytes centrally after 4 h of segmental perfusion. Conclusion Ex vivo hepatic segmental perfusion is technically challenging but its success in a porcine model and the principles learned should facilitate the development of an analogous human model using discarded tissue following formal liver resections. The model would use a healthy liver segment following a major formal resection such as a hemi-hepatectomy and ex vivo perfusion performed via a segmental hepatic artery and portal vein. If successful this model would represent a significant development and enable ethical translation research to assess the response of human livers to a variety of stressors, including toxicity and infection.

Indexed as

extra-corporealex-vivohepaticliverperfusion

Identifiers

PMID36949973
PMCPMC10027018
OpenAlexW4321328681

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read21
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.